Navamedic - Earnings Release 2015

Significantly improved profitability

Navamedic ASA today announced the Company's first quarter 2015 financial

results. Navamedic's profitability improved significantly from last year's first

quarter, while sales increased by 44 per cent.

Navamedic had sales of NOK 61.8 million in the first quarter, compared to NOK

42.9 million last year.

The Company's EBITDA for the quarter was NOK 4.2 million, compared to NOK 2.0

million the first quarter of 2014. Earnings before taxes for the first quarter

this year ended at NOK 1.5 million, against NOK 0.2 million last year.

All of Navamedic's three segments - Pharma, Medical Nutrition and Consumer Care

- experienced sales growth and improved profitability in the first quarter. Of

the geographical markets, Finland was the growth winner with a tripling of sales

in the first quarter.

For further information, please contact interim CEO Håkan Josephsson, telephone

+46 706 742 533 or CFO Bjørn Lindholt, telephone +47 9300 6601.

Navamedic ASA is a Norwegian pharmaceutical products company, marketing and

distributing more than 120 products in the Nordic and Benelux markets. The

Company operates three business areas; Pharma Products, Medical Nutrition and

Consumer Care based on its relationship with a number of pharmaceutical product

manufacturers. Navamedic is listed on the Oslo Stock Exchange (ticker: NAVA).

[HUG#1915511]

AI assistant